scholarly article | Q13442814 |
P356 | DOI | 10.1006/CYTO.1999.0485 |
P698 | PubMed publication ID | 10525310 |
P2093 | author name string | J Brush | |
A Goddard | |||
J Foster | |||
Q Gu | |||
P Dowd | |||
A Vagts | |||
J Liang | |||
A Huang | |||
A L Gurney | |||
M H Xie | |||
K Hillan | |||
B Deuel | |||
I Holcomb | |||
P2860 | cites work | The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain | Q24306718 |
Receptor specificity of the fibroblast growth factor family | Q24320178 | ||
Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13) | Q24676891 | ||
The molecular biology of heparan sulfate fibroblast growth factor receptors | Q28237163 | ||
Association of a 85-kDa serine kinase with activated fibroblast growth factor receptor-4 | Q28274266 | ||
Expression and biological activity of mouse fibroblast growth factor-9 | Q28274286 | ||
Fibroblast growth factor receptors have different signaling and mitogenic potentials | Q28609648 | ||
FGFR activation in skeletal disorders: too much of a good thing | Q28646375 | ||
Osteoporosis-pseudoglioma syndrome: clinical, morphological, and biochemical studies | Q33751328 | ||
Craniosynostosis: genes and mechanisms | Q34439564 | ||
Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation | Q36219245 | ||
Direct demonstration of MuSK involvement in acetylcholine receptor clustering through identification of agonist ScFv | Q36876183 | ||
Receptor binding and mitogenic properties of mouse fibroblast growth factor 3. Modulation of response by heparin | Q38290375 | ||
Nature of the interaction of heparin with acidic fibroblast growth factor | Q38319104 | ||
Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells | Q38331586 | ||
Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules | Q38345199 | ||
Fibroblast growth factors: at the heart of angiogenesis | Q40403288 | ||
Functions of fibroblast growth factors in vertebrate development | Q40918251 | ||
bFGF and aFGF induce membrane ruffling in breast cancer cells but not in normal breast epithelial cells: FGFR-4 involvement | Q41946450 | ||
Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis | Q42476789 | ||
FGF signaling in skeletal development. | Q47768464 | ||
Genomic organization of the mouse fibroblast growth factor receptor 3 (Fgfr3) gene | Q48069156 | ||
Osteoporosis-pseudoglioma syndrome: report of three affected sibs and an overview. | Q52082036 | ||
High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells | Q70175493 | ||
Expression of FGF and FGF receptor genes in human breast cancer | Q72131492 | ||
Heparin-induced self-association of fibroblast growth factor-2. Evidence for two oligomerization processes | Q73442763 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | fibroblast growth factor binding | Q14866184 |
fibroblast growth factor receptor 4 | Q21137668 | ||
Fibroblast growth factor 19 | Q21172797 | ||
P304 | page(s) | 729-35 | |
P577 | publication date | 1999-10-01 | |
P1433 | published in | Cytokine | Q15745296 |
P1476 | title | FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4 | |
P478 | volume | 11 |